MedTrace Logo

Prenatal Carrier Screening for Spinal Muscular Atrophy Among Thai Pregnant Women

NCT04859179 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-04-26

No results posted yet for this study

Summary

Spinal muscular atrophy (SMA) prenatal carrier screening is recommended by American College of Medical Genetics (ACMG) and American College of Obstetrics and Gynecology (ACOG). However, in Thailand, there are no standard protocol for SMA prenatal carrier screening.

Conditions

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Chayada Tangshewinsirikul · Ramathibodi Hospital, Mahidol University

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-10
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04859179 on ClinicalTrials.gov